A Japan­ese biotech found­ed by Treg cell dis­cov­er­er moves to the US with $45.8M

Cell ther­a­py biotech Reg­Cell is hop­ing to bridge sci­ence from Japan with the US biotech in­dus­try to de­vel­op new cell ther­a­pies for au­toim­mune con­di­tions. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER